BRPI0921148A2 - composto, método para tratar uma infecção bacteriana, e, uso de um composto. - Google Patents
composto, método para tratar uma infecção bacteriana, e, uso de um composto.Info
- Publication number
- BRPI0921148A2 BRPI0921148A2 BRPI0921148A BRPI0921148A BRPI0921148A2 BR PI0921148 A2 BRPI0921148 A2 BR PI0921148A2 BR PI0921148 A BRPI0921148 A BR PI0921148A BR PI0921148 A BRPI0921148 A BR PI0921148A BR PI0921148 A2 BRPI0921148 A2 BR PI0921148A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- treating
- bacterial infection
- bacterial
- infection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11470608P | 2008-11-14 | 2008-11-14 | |
| US16384809P | 2009-03-26 | 2009-03-26 | |
| PCT/GB2009/051532 WO2010055348A1 (en) | 2008-11-14 | 2009-11-13 | [4- (1-amino-ethyl) -cyclohexyl] -methyl-amines as antibacterials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0921148A2 true BRPI0921148A2 (pt) | 2016-02-23 |
Family
ID=41463108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0921148A BRPI0921148A2 (pt) | 2008-11-14 | 2009-11-13 | composto, método para tratar uma infecção bacteriana, e, uso de um composto. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20110288084A1 (pt) |
| EP (1) | EP2370444A1 (pt) |
| JP (1) | JP2012508789A (pt) |
| KR (1) | KR20110093797A (pt) |
| CN (1) | CN102216308A (pt) |
| AR (1) | AR074340A1 (pt) |
| AU (1) | AU2009315425A1 (pt) |
| BR (1) | BRPI0921148A2 (pt) |
| CA (1) | CA2742520A1 (pt) |
| CO (1) | CO6382113A2 (pt) |
| CR (1) | CR20110256A (pt) |
| CU (1) | CU20110108A7 (pt) |
| EA (1) | EA201100754A1 (pt) |
| EC (1) | ECSP11011053A (pt) |
| IL (1) | IL211941A0 (pt) |
| MX (1) | MX2011005106A (pt) |
| TW (1) | TW201022279A (pt) |
| UY (1) | UY32247A (pt) |
| WO (1) | WO2010055348A1 (pt) |
| ZA (1) | ZA201104395B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014518267A (ja) * | 2011-06-27 | 2014-07-28 | 杏林製薬株式会社 | 細菌感染症の治療のための架橋二環式化合物 |
| AR096135A1 (es) * | 2013-05-02 | 2015-12-09 | Actelion Pharmaceuticals Ltd | Derivados de la quinolona |
| UY36851A (es) * | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | Compuestos para uso en aplicaciones antibacterianas |
| AR105911A1 (es) | 2015-09-03 | 2017-11-22 | Forma Therapeutics Inc | Inhibidores de hdac8 bicíclicos fusionados [6,6] |
| EP3468975B1 (en) * | 2016-06-08 | 2020-04-01 | Aziende Chimiche Riunite Angelini Francesco A.C.R. | New antibacterial compounds |
| US10912780B2 (en) | 2017-06-08 | 2021-02-09 | Bugworks Research, Inc. | Heterocyclic compounds useful as anti-bacterial agents and method for production thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY150958A (en) * | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
| MX2008014908A (es) * | 2006-05-26 | 2009-05-13 | Toyama Chemical Co Ltd | Compuesto heterociclico nuevo o sal del mismo e intermedio del mismo. |
| CL2007003693A1 (es) * | 2006-12-22 | 2008-06-27 | Actelion Pharmaceuticals Ltd | Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas. |
-
2009
- 2009-11-12 TW TW098138483A patent/TW201022279A/zh unknown
- 2009-11-13 KR KR1020117010967A patent/KR20110093797A/ko not_active Withdrawn
- 2009-11-13 CN CN2009801457755A patent/CN102216308A/zh active Pending
- 2009-11-13 EA EA201100754A patent/EA201100754A1/ru unknown
- 2009-11-13 AU AU2009315425A patent/AU2009315425A1/en not_active Abandoned
- 2009-11-13 JP JP2011543815A patent/JP2012508789A/ja active Pending
- 2009-11-13 EP EP09753199A patent/EP2370444A1/en not_active Withdrawn
- 2009-11-13 WO PCT/GB2009/051532 patent/WO2010055348A1/en not_active Ceased
- 2009-11-13 BR BRPI0921148A patent/BRPI0921148A2/pt not_active Application Discontinuation
- 2009-11-13 UY UY0001032247A patent/UY32247A/es not_active Application Discontinuation
- 2009-11-13 CA CA2742520A patent/CA2742520A1/en not_active Abandoned
- 2009-11-13 US US13/128,596 patent/US20110288084A1/en not_active Abandoned
- 2009-11-13 AR ARP090104378A patent/AR074340A1/es unknown
- 2009-11-13 MX MX2011005106A patent/MX2011005106A/es not_active Application Discontinuation
-
2011
- 2011-03-24 IL IL211941A patent/IL211941A0/en unknown
- 2011-05-11 CO CO11058050A patent/CO6382113A2/es not_active Application Discontinuation
- 2011-05-13 CU CU20110108A patent/CU20110108A7/es unknown
- 2011-05-13 EC EC2011011053A patent/ECSP11011053A/es unknown
- 2011-05-13 CR CR20110256A patent/CR20110256A/es not_active Application Discontinuation
- 2011-06-13 ZA ZA2011/04395A patent/ZA201104395B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201104395B (en) | 2012-03-28 |
| IL211941A0 (en) | 2011-06-30 |
| JP2012508789A (ja) | 2012-04-12 |
| TW201022279A (en) | 2010-06-16 |
| ECSP11011053A (es) | 2011-06-30 |
| WO2010055348A1 (en) | 2010-05-20 |
| US20110288084A1 (en) | 2011-11-24 |
| MX2011005106A (es) | 2011-05-30 |
| CO6382113A2 (es) | 2012-02-15 |
| CA2742520A1 (en) | 2010-05-20 |
| EP2370444A1 (en) | 2011-10-05 |
| AR074340A1 (es) | 2011-01-12 |
| UY32247A (es) | 2010-06-30 |
| CR20110256A (es) | 2011-07-04 |
| CU20110108A7 (es) | 2012-01-31 |
| EA201100754A1 (ru) | 2012-01-30 |
| CN102216308A (zh) | 2011-10-12 |
| KR20110093797A (ko) | 2011-08-18 |
| AU2009315425A1 (en) | 2010-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0815057A2 (pt) | Composto, composição farmacêutica, e, método para tratar infecção. | |
| BRPI0922475A2 (pt) | composto, composição farmacêutica , método para tratar câncer, e, uso de um composto. | |
| BRPI1013984A2 (pt) | composto , composição farmacêutica, método para tratamento ou profilaxia de uma doença ou condição, e, uso de um composto. | |
| BRPI0815409A2 (pt) | Cepa bacteriana, processos para a produção fermentativa de um composto, e para a produção de um composto, e, uso de uma cepa bacteriana. | |
| BRPI1015983A2 (pt) | composto, uso do composto, método para tratar um paciente, e, composição farmacêutica. | |
| BRPI1010775A2 (pt) | composição, método para preparar uma composição, e, uso de uma composição. | |
| BRPI1008383A2 (pt) | composto, composição farmacêutica, método para prevenir, inibir ou tratar uma condição, e, uso de um composto | |
| BRPI0917458A2 (pt) | composto, método de tratamento de doenças e condições, composição farmacêutica, método para tratar ou prevenir doença, e, uso de um composto | |
| BRPI0908100A2 (pt) | produto combinação, uso de um composto, e, método de tratar câncer | |
| BRPI0920263A2 (pt) | composto, uso do composto, composição, e, método | |
| BRPI0813237A2 (pt) | Composto, método para preparar o composto, composição, medicamento, e, uso do composto. | |
| BR112012022879A2 (pt) | composto, composição farmacêutica, uso do composto e método de tratamento | |
| BRPI0814941A2 (pt) | Composição de tratamentode semente, e, método de tratamento de semente. | |
| BRPI0919937A2 (pt) | composto, e, método para melhorar a atividade de adjuvante de uma imidazoquinolina | |
| BRPI0907976A2 (pt) | Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças | |
| BRPI0912539A2 (pt) | composto, composição farmacêutica , método para tratar uma doença, e, uso do composto. | |
| BRPI0814300A2 (pt) | Composto, composição farmacêutica, e, método para tratar uma infecção viral | |
| BRPI0718661A2 (pt) | Método para prevenir o crescimento de microorganismos, e uma combinação para a prevenção do crescimento microbiano | |
| BRPI0907974A2 (pt) | Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças | |
| BRPI0908635A2 (pt) | composto, composição farmacêutica e método de tratamento de câncer | |
| BRPI0815591A2 (pt) | Composto, composição farmacêutica, uso de um composto, e, método para tratar uma doença, condição ou distúrbio. | |
| BRPI0916649A2 (pt) | Composto, composição, uso de um composto, e, método para exterminar ou inibir o crescimento de uma espécie de plasmodium. | |
| BRPI0908883A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças | |
| BRPI0818323A2 (pt) | composição farmacêutica, uso de uma composição farmacêutica, e, método para tratar câncer. | |
| BRPI0923856A2 (pt) | composto, composição farmacêutica, uso de um composto, e método para tratar uma doença ou distúrbio. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |